Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibudilast for methamphetamine dependence
NCT01860807Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ibudilast in methamphetamine use disorder (MUD), sponsored by University of California, Los Angeles. Started Jul 2013; status: completed.
02
Drugs
ibudilast
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT01860807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01860807.